Singapore markets open in 5 hours 44 minutes
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,067.60 -2.95 (-0.06%) Dow
38,437.96 -65.73 (-0.17%) Nasdaq
15,698.57 +1.93 (+0.01%) Bitcoin USD
64,218.09 -2,526.12 (-3.78%) CMC Crypto 200
1,386.49 -37.61 (-2.64%)
ABBV Jan 2025 175.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:56PM EDT. Market open.
| Previous close | 11.35 |
| Open | 10.10 |
| Bid | 10.25 |
| Ask | 10.45 |
| Strike | 175.00 |
| Expiry date | 2025-01-17 |
| Day's range | 10.10 - 10.60 |
| Contract range | N/A |
| Volume | |
| Open interest | 6.45k |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
© 2024 Yahoo. All rights reserved.